Publications by authors named "Elihu Estey"

100Publications

Acute myeloid leukemia: 2021 update on risk-stratification and management.

Authors:
Elihu H Estey

Am J Hematol 2020 Aug 24. Epub 2020 Aug 24.

Division of Hematology, University of Washington, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25975DOI Listing
August 2020

Truth or consequences: under-reporting of post-accrual changes in clinical trial design.

Leuk Lymphoma 2020 Sep 22;61(9):2034-2035. Epub 2020 Jun 22.

Division of Hematology, Department of Medicine, University of Washington, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2020.1779262DOI Listing
September 2020

Selection of initial therapy for newly-diagnosed adult acute myeloid leukemia: Limitations of predictive models.

Blood Rev 2020 Mar 30:100679. Epub 2020 Mar 30.

Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA 98109-1024, USA; Department of Medicine, Division of Hematology, University of Washington, 1959 NE Pacific St, Seattle, WA 98195-7710, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2020.100679DOI Listing
March 2020

Follow-up issues in survivors of hematologic malignancies - Current stance and future perspectives.

Blood Rev 2020 Feb 26:100674. Epub 2020 Feb 26.

Oncology Center, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia; Department of Medicine, Mayo Clinic, Rochester, MN, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2020.100674DOI Listing
February 2020

Recent drug approvals for newly diagnosed acute myeloid leukemia: gifts or a Trojan horse?

Leukemia 2020 03 8;34(3):671-681. Epub 2020 Jan 8.

Haematology Research Centre, Department of Immunology and Inflammation, Imperial College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-019-0704-5DOI Listing
March 2020

New drug approvals in acute myeloid leukemia: an unprecedented paradigm shift.

Clin Adv Hematol Oncol 2019 Oct;17(10):569-575

Fred Hutchinson Cancer Research Center, Seattle, Washington.

View Article

Download full-text PDF

Source
October 2019

Need for routine examination of left ventricular ejection fraction in patients with AML.

Leukemia 2020 04 12;34(4):1169-1171. Epub 2019 Nov 12.

Division of Hematology, Department of Medicine, University of Washington, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-019-0637-zDOI Listing
April 2020

Independent Associations Between Glomerular Filtration Rate and Serum Bilirubin Level and Early Mortality in Acute Myeloid Leukemia.

Clin Lymphoma Myeloma Leuk 2019 12 1;19(12):e633-e635. Epub 2019 Aug 1.

Department of Medicine, University of Washington, Seattle, WA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Seattle Cancer Care Alliance, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2019.06.014DOI Listing
December 2019

Current treatment strategies for measurable residual disease in patients with acute myeloid leukemia.

Cancer 2019 Sep 10;125(18):3121-3130. Epub 2019 Jul 10.

Division of Hematology, Department of Medicine, University of Washington, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.32354DOI Listing
September 2019

More Versus Less Therapy for Older Adults With Acute Myeloid Leukemia: New Perspectives on an Old Debate.

Am Soc Clin Oncol Educ Book 2019 Jan 17;39:421-432. Epub 2019 May 17.

3 The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_239097DOI Listing
January 2019

Revised Acute Myeloid Leukemia Composite Model Using the 2017 European LeukemiaNet Risk Classification.

JAMA Oncol 2019 Jul;5(7):1062-1064

Division of Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2019.0902DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537840PMC
July 2019

Diagnostic utility of bronchoscopy in adults with acute myeloid leukemia and other high-grade myeloid neoplasms.

Leuk Lymphoma 2019 09 11;60(9):2304-2307. Epub 2019 Mar 11.

Clinical Research Division, Fred Hutchinson Cancer Research Center , Seattle , WA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1581933DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739192PMC
September 2019

New study-designs to address the clinical complexity of acute myeloid leukemia.

Leukemia 2019 03 22;33(3):567-569. Epub 2019 Jan 22.

R. P. Gale - Haematology Research Centre, Division of Experimental Medicine, Department of Medicine, Imperial College London, London, UK.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41375-018-0363-y
Publisher Site
http://dx.doi.org/10.1038/s41375-018-0363-yDOI Listing
March 2019

'Looking beyond survival to define therapeutic value in acute myeloid leukemia'.

Authors:
Elihu Estey

Leuk Lymphoma 2019 05 10;60(5):1107-1109. Epub 2019 Jan 10.

a Division of Hematology , University of Washington and Clinical Research Division, Fred Hutchinson Cancer Research Center , Seattle , WA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2018.1543886DOI Listing
May 2019

Gemtuzumab ozogamicin in acute myeloid leukemia: act 2, with perhaps more to come.

Haematologica 2019 01;104(1):7-9

Division of Hematology University of Washington Medical Center and Clinical Research Division Fred Hutchinson Cancer Research Center Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2018.205948DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312009PMC
January 2019

Outpatient induction and consolidation care strategies in acute myeloid leukemia.

Curr Opin Hematol 2019 03;26(2):65-70

Division of Hematology, Department of Medicine.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOH.0000000000000481DOI Listing
March 2019

Acute myeloid leukemia: 2019 update on risk-stratification and management.

Authors:
Elihu H Estey

Am J Hematol 2018 10;93(10):1267-1291

Division of Hematology, Clinical Research Division, Fred Hutchinson Cancer Research Center, University of Washington and Member, Seattle, Washington.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ajh.25214
Publisher Site
http://dx.doi.org/10.1002/ajh.25214DOI Listing
October 2018

New drugs in AML: uses and abuses.

Leukemia 2018 07 6;32(7):1479-1481. Epub 2018 Jun 6.

Leukemia Program, Cleveland Clinic, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-018-0168-zDOI Listing
July 2018

Incorporating Physical Function and Cognition Into Mortality Risk Assessment for Acute Myeloid Leukemia-Reply.

JAMA Oncol 2018 07;4(7):1014-1015

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2018.0677DOI Listing
July 2018

Time to repeal and replace response criteria for acute myeloid leukemia?

Blood Rev 2018 09 27;32(5):416-425. Epub 2018 Mar 27.

The Alfred Hospital and Monash University, Melbourne, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2018.03.006DOI Listing
September 2018

Deep NPM1 Sequencing Following Allogeneic Hematopoietic Cell Transplantation Improves Risk Assessment in Adults with NPM1-Mutated AML.

Biol Blood Marrow Transplant 2018 08 21;24(8):1615-1620. Epub 2018 Apr 21.

Department of Laboratory Medicine, Division of Hematopathology, University of Washington, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.04.017DOI Listing
August 2018

Developing an instrument to assess patient preferences for benefits and risks of treating acute myeloid leukemia to promote patient-focused drug development.

Curr Med Res Opin 2018 12 27;34(12):2031-2039. Epub 2018 Apr 27.

a Department of Health Policy and Management , Johns Hopkins Bloomberg School of Public Health , Baltimore , MD , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/03007995.2018.1456414DOI Listing
December 2018

Widespread use of measurable residual disease in acute myeloid leukemia practice.

Leuk Res 2018 04 13;67:92-98. Epub 2018 Feb 13.

Department of Medicine, Memorial Sloan Kettering Cancer Center, USA; Division of Hematologic Oncology, Leukemia Service, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY, 10065, USA; Department of Medicine, Weill Cornell Medical College, 1300 York Ave, New York, NY, 10065, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2018.02.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029617PMC
April 2018

Allogeneic Transplantation for Acute Myelogenous Leukemia in CR1.

Authors:
Elihu Estey

Biol Blood Marrow Transplant 2018 02 14;24(2):205-206. Epub 2017 Dec 14.

Division of Hematology, University of Washington School of Medicine, Clinical Research Division Fred Hutchinson Cancer Research Center, Seattle, Washington. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.12.773DOI Listing
February 2018

Emerging treatments in acute myeloid leukemia: current standards and unmet challenges.

Clin Adv Hematol Oncol 2017 Aug;15(8):632-642

Division of Hematology, University of Washington School of Medicine, Seattle, Washington.

View Article

Download full-text PDF

Source
August 2017

A case of indolent AML with five-year survival without treatment.

Leuk Lymphoma 2018 02 22;59(2):519. Epub 2017 Jun 22.

b Seattle Cancer Care Alliance Hematology , Seattle , WA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1330471DOI Listing
February 2018

Day 14 bone marrow examination in the management of acute myeloid leukemia.

Am J Hematol 2017 Oct 19;92(10):1079-1084. Epub 2017 Jul 19.

Division of Hematology and Oncology, Rhode Island Hospital/Brown University Warren Alpert Medical School, Providence, Rhode Island.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24818DOI Listing
October 2017

Flow cytometric demonstration of decrease in bone marrow leukemic blasts after 'Day 14' without further therapy in acute myeloid leukemia.

Leuk Lymphoma 2017 11 28;58(11):2717-2719. Epub 2017 Mar 28.

c Clinical Research Division , Fred Hutchinson Cancer Research Center , Seattle , WA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1307359DOI Listing
November 2017

Bone marrow evaluation for diagnosis and monitoring of acute myeloid leukemia.

Blood Rev 2017 07 2;31(4):185-192. Epub 2017 Feb 2.

Myeloid Malignancies Section, Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2017.01.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513766PMC
July 2017

Acute Myeloid Leukemia - Many Diseases, Many Treatments.

Authors:
Elihu Estey

N Engl J Med 2016 11;375(21):2094-2095

From the Division of Hematology, University of Washington Medical Center, and the Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMe1611424DOI Listing
November 2016

Why are there so few randomized trials for patients with primary refractory acute myeloid leukemia?

Authors:
Elihu Estey

Best Pract Res Clin Haematol 2016 12 18;29(4):324-328. Epub 2016 Oct 18.

University of Washington/Fred Hutchinson Cancer Research Center, 825 Eastlake Ave E, Mailstop G3-200, Seattle, WA 98109, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2016.10.003DOI Listing
December 2016

Assessment of Minimal Residual Disease in Standard-Risk AML.

N Engl J Med 2016 08;375(6):e9

Imperial College London, London, United Kingdom.

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMc1603847
Publisher Site
http://dx.doi.org/10.1056/NEJMc1603847DOI Listing
August 2016

Acute myeloid leukemia: 2016 Update on risk-stratification and management.

Authors:
Elihu Estey

Am J Hematol 2016 08;91(8):824-46

Division of Hematology, University of Washington School of Medicine, Seattle, WA, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24439DOI Listing
August 2016

Infusion of a non-HLA-matched ex-vivo expanded cord blood progenitor cell product after intensive acute myeloid leukaemia chemotherapy: a phase 1 trial.

Lancet Haematol 2016 Jul 7;3(7):e330-9. Epub 2016 Jun 7.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Medical Oncology, University of Washington, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(16)30023-0DOI Listing
July 2016

Moving toward targeted therapies in acute myeloid leukemia.

Clin Adv Hematol Oncol 2015 Nov;13(11):748-54

Fred Hutchinson Cancer Research Center, Seattle, Washington and the University of Washington, Seattle, Washington.

View Article

Download full-text PDF

Source
November 2015

Variability in management of hematologic malignancy patients with venous thromboembolism and chemotherapy-induced thrombocytopenia.

Thromb Res 2016 May 12;141:104-5. Epub 2016 Mar 12.

Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.thromres.2016.03.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308208PMC
May 2016

Prediction of early death in adults with relapsed or refractory acute myeloid leukemia.

Leuk Lymphoma 2016 10 11;57(10):2421-4. Epub 2016 Jan 11.

c Clinical Research Division , Fred Hutchinson Cancer Research Center , Seattle , WA , USA ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2015.1135436DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5003083PMC
October 2016

Does outcome of second salvage therapy in relapsed or refractory acute myeloid leukemia depend on intensity of either first or second salvage therapy?

Leuk Lymphoma 2016 May 23;57(5):1205-7. Epub 2015 Dec 23.

c Department of Medicine, Division of Hematology , University of Washington , Seattle , WA , USA ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2015.1079316DOI Listing
May 2016

Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia: Time to Move Toward a Minimal Residual Disease-Based Definition of Complete Remission?

J Clin Oncol 2016 Feb 14;34(4):329-36. Epub 2015 Dec 14.

Daisuke Araki, Brent L. Wood, Jerald P. Radich, Anna B. Halpern, Yi Zhou, Marco Mielcarek, Elihu H. Estey, Frederick R. Appelbaum, and Roland B. Walter, University of Washington; and Megan Othus, Jerald P. Radich, Marco Mielcarek, Elihu H. Estey, Frederick R. Appelbaum, and Roland B. Walter, Fred Hutchinson Cancer Research Center, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.3826DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872033PMC
February 2016

Resource Utilization and Safety of Outpatient Management Following Intensive Induction or Salvage Chemotherapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome: A Nonrandomized Clinical Comparative Analysis.

JAMA Oncol 2015 Nov;1(8):1120-7

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington6Division of Hematology, Department of Medicine, University of Washington, Seattle8Department of Epidemiology, University of Washington, Seattle.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2015.2969DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720981PMC
November 2015

Reply to D. Przepiorka et al.

J Clin Oncol 2015 Nov 17;33(31):3676-7. Epub 2015 Aug 17.

Fred Hutchinson Cancer Research Center; and University of Washington, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.0749DOI Listing
November 2015

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs.

Authors:
Ayalew Tefferi Hagop Kantarjian S Vincent Rajkumar Lawrence H Baker Jan L Abkowitz John W Adamson Ranjana Hira Advani James Allison Karen H Antman Robert C Bast John M Bennett Edward J Benz Nancy Berliner Joseph Bertino Ravi Bhatia Smita Bhatia Deepa Bhojwani Charles D Blanke Clara D Bloomfield Linda Bosserman Hal E Broxmeyer John C Byrd Fernando Cabanillas George Peter Canellos Bruce A Chabner Asher Chanan-Khan Bruce Cheson Bayard Clarkson Susan L Cohn Gerardo Colon-Otero Jorge Cortes Steven Coutre Massimo Cristofanilli Walter J Curran George Q Daley Daniel J DeAngelo H Joachim Deeg Lawrence H Einhorn Harry P Erba Francisco J Esteva Elihu Estey Isaiah J Fidler James Foran Stephen Forman Emil Freireich Charles Fuchs James N George Morie A Gertz Sergio Giralt Harvey Golomb Peter Greenberg Jordan Gutterman Robert I Handin Samuel Hellman Paulo Marcelo Hoff Ronald Hoffman Waun Ki Hong Mary Horowitz Gabriel N Hortobagyi Clifford Hudis Jean Pierre Issa Bruce Evan Johnson Philip W Kantoff Kenneth Kaushansky David Khayat Fadlo R Khuri Thomas J Kipps Margaret Kripke Robert A Kyle Richard A Larson Theodore S Lawrence Ross Levine Michael P Link Scott M Lippman Sagar Lonial Gary H Lyman Maurie Markman John Mendelsohn Neal J Meropol Yoav Messinger Therese M Mulvey Susan O'Brien Roman Perez-Soler Raphael Pollock Josef Prchal Oliver Press Jerald Radich Kanti Rai Saul A Rosenberg Jacob M Rowe Hope Rugo Carolyn D Runowicz Brenda M Sandmaier Alan Saven Andrew I Schafer Charles Schiffer Mikkael A Sekeres Richard T Silver Lillian L Siu David P Steensma F Marc Stewart Wendy Stock Richard Stone Rainer Storb Louise C Strong Martin S Tallman Michael Thompson Naoto T Ueno Richard A Van Etten Julie M Vose Peter H Wiernik Eric P Winer Anas Younes Andrew D Zelenetz Charles A LeMaistre

Mayo Clin Proc 2015 Aug 23;90(8):996-1000. Epub 2015 Jul 23.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2015.06.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5365030PMC
August 2015

Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOG.

Haematologica 2015 Oct 9;100(10):e409-11. Epub 2015 Jul 9.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2015.130013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4591777PMC
October 2015

Why Is Progress in Acute Myeloid Leukemia So Slow?

Authors:
Elihu Estey

Semin Hematol 2015 Jul 17;52(3):243-8. Epub 2015 Mar 17.

Division of Hematology University of Washington Medical Center and Fred Hutchinson Cancer Research Institute, Seattle, WA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminhematol.2015.03.007DOI Listing
July 2015

Prognostic significance of acquired copy-neutral loss of heterozygosity in acute myeloid leukemia.

Cancer 2015 Sep 29;121(17):2900-8. Epub 2015 May 29.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29475DOI Listing
September 2015

Comparative analysis of flow cytometry and morphology for the detection of acute myeloid leukaemia cells in cerebrospinal fluid.

Br J Haematol 2016 Jan 26;172(1):134-6. Epub 2015 May 26.

Clinical Research Division, Fred Hutchinson Cancer Research Centre, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13465DOI Listing
January 2016

Effect of allogeneic hematopoietic cell transplantation in first complete remission on post-relapse complete remission rate and survival in acute myeloid leukemia.

Haematologica 2015 Jul 20;100(7):e254-6. Epub 2015 Mar 20.

Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA Clinical Research Division, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2014.118570DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486235PMC
July 2015

Current challenges in clinical development of "targeted therapies": the case of acute myeloid leukemia.

Blood 2015 Apr 11;125(16):2461-6. Epub 2015 Mar 11.

Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-01-561373DOI Listing
April 2015

Relation of clinical response and minimal residual disease and their prognostic impact on outcome in acute myeloid leukemia.

J Clin Oncol 2015 Apr 2;33(11):1258-64. Epub 2015 Mar 2.

Xueyan Chen, Brent L. Wood, Roland B. Walter, Pamela S. Becker, Janis L. Abkowitz, and Elihu H. Estey, University of Washington; and Hu Xie, Roland B. Walter, John M. Pagel, Pamela S. Becker, Vicky K. Sandhu, Frederick R. Appelbaum, and Elihu H. Estey, Fred Hutchinson Cancer Research Center, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.58.3518DOI Listing
April 2015

Elevated lymphocyte count at time of acute myeloid leukemia diagnosis is associated with shorter remission.

Leuk Lymphoma 2015 12;56(11):3109-15. Epub 2015 May 12.

a Division of Clinical Research, Fred Hutchinson Cancer Research Center , Seattle , WA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2015.1020060DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4714707PMC
September 2016

Prognostic significance of NPM1 mutations in the absence of FLT3-internal tandem duplication in older patients with acute myeloid leukemia: a SWOG and UK National Cancer Research Institute/Medical Research Council report.

J Clin Oncol 2015 Apr 23;33(10):1157-64. Epub 2015 Feb 23.

Fabiana Ostronoff, Megan Othus, Elihu Estey, Frederick R. Appelbaum, Kenneth J. Kopecky, Min Fang, Vivian G. Oehler, Era L. Pogosova-Agadjanyan, Jerald P. Radich, Soheil Meshinchi, and Derek L. Stirewalt, Fred Hutchinson Cancer Research Center; Fabiana Ostronoff, Elihu Estey, Frederick R. Appelbaum, Min Fang, Vivian G. Oehler, Jerald P. Radich, and Derek L. Stirewalt, University of Washington; Stephen H. Petersdorf, Seattle Genetics, Seattle, WA; Michelle Lazenby, Anna Evans, Amanda Gilkes, and Alan Burnett, Cardiff University School of Medicine, Cardiff, United Kingdom; John Godwin, Providence Cancer Center Group and Earle A. Chiles Research Institute, Portland, OR; Alan F. List, H. Lee Moffitt Cancer Center, Tampa, FL; and Cheryl L. Willman, University of New Mexico, Albuquerque, NM.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/33/10/1157.full.pdf
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.58.0571
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.58.0571DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372852PMC
April 2015

Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in older adults.

Hematology Am Soc Hematol Educ Program 2014 Dec 18;2014(1):21-33. Epub 2014 Nov 18.

Division of Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA.

View Article

Download full-text PDF

Source
http://www.asheducationbook.org/cgi/doi/10.1182/asheducation
Publisher Site
http://dx.doi.org/10.1182/asheducation-2014.1.21DOI Listing
December 2014

Sorafenib treatment following hematopoietic stem cell transplant in pediatric FLT3/ITD acute myeloid leukemia.

Pediatr Blood Cancer 2015 Jun 8;62(6):1048-54. Epub 2015 Feb 8.

Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Hematology and Oncology, Seattle Children's Hospital, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.25437DOI Listing
June 2015

Central nervous system involvement in acute myeloid leukemia patients undergoing hematopoietic cell transplantation.

Biol Blood Marrow Transplant 2015 Mar 26;21(3):546-51. Epub 2014 Dec 26.

Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Medicine, University of Washington, Seattle, Washington.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791140139
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2014.11.683DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720268PMC
March 2015

Correlation between peripheral blood and bone marrow regarding FLT3-ITD and NPM1 mutational status in patients with acute myeloid leukemia.

Haematologica 2015 Mar 19;100(3):e97-8. Epub 2014 Dec 19.

Department of Medicine/Division of Hematology, University of Washington, Seattle, WA Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2014.118422DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349287PMC
March 2015

Primacy of resistance rather than toxicity in determining outcome of therapy for AML.

Authors:
Elihu H Estey

Clin Lymphoma Myeloma Leuk 2014 Sep;14 Suppl:S56-8

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Division of Hematology, Department of Medicine, University of Washington School of Medicine, Seattle, WA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2014.04.016DOI Listing
September 2014

Management of persistent AML at day 14.

Authors:
Elihu Estey

Best Pract Res Clin Haematol 2014 Sep-Dec;27(3-4):235-40. Epub 2014 Oct 15.

University of Washington, Fred Hutchinson Cancer Research Center, 825 Eastlake Ave E, Mailstop G3-200, Seattle, WA 98109, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15216926140007
Publisher Site
http://dx.doi.org/10.1016/j.beha.2014.10.004DOI Listing
July 2015

Acute myeloid leukemia: 2014 update on risk-stratification and management.

Authors:
Elihu H Estey

Am J Hematol 2014 Nov;89(11):1063-81

Division of Hematology, University of Washington and Member, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.23834DOI Listing
November 2014

Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation.

J Clin Oncol 2014 Oct 25;32(29):3249-56. Epub 2014 Aug 25.

Mohamed L. Sorror, Rainer F. Storb, Brenda M. Sandmaier, Fabiana Ostronoff, H. Joachim Deeg, Karen L. Syrjala, Elihu Estey, David G. Maloney, Frederick R. Appelbaum, Paul J. Martin, and Barry E. Storer, Fred Hutchinson Cancer Research Center; Mohamed L. Sorror, Rainer F. Storb, Brenda M. Sandmaier, Fabiana Ostronoff, H. Joachim Deeg, Karen L. Syrjala, Elihu Estey, David G. Maloney, Frederick R. Appelbaum, and Paul J. Martin, University of Washington School of Medicine; Barry E. Storer, University of Washington School of Public Health, Seattle, WA; Smita Bhatia, City of Hope School of Medicine, Duarte, CA; Richard T. Maziarz, Center for Hematologic Malignancies, Oregon Health & Science University Knight Cancer Institute and School of Medicine, Portland, OR; Michael A. Pulsipher, University of Utah School of Medicine and Primary Children's Medical Center, Huntsman Cancer Institute, Salt Lake City, UT; and Michael B. Maris, Colorado Blood Cancer Institute School of Medicine, Denver, CO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.53.8157DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4178523PMC
October 2014

Factors associated with early reinduction chemotherapy for adults with acute myeloid leukemia.

Leuk Lymphoma 2015 Mar 17;56(3):782-4. Epub 2014 Jul 17.

Department of Medicine, University of Washington , Seattle, WA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2014.928931DOI Listing
March 2015

The past and future of CD33 as therapeutic target in acute myeloid leukemia.

Blood Rev 2014 Jul 21;28(4):143-53. Epub 2014 Apr 21.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA; Department of Epidemiology, University of Washington, Seattle, WA, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0268960X140003
Publisher Site
http://dx.doi.org/10.1016/j.blre.2014.04.001DOI Listing
July 2014